Pyrimidine metabolism regulator-mediated molecular subtypes display tumor microenvironmental hallmarks and assist precision treatment in bladder cancer
BackgroundBladder cancer (BLCA) is a common urinary system malignancy with a significant morbidity and death rate worldwide. Non-muscle invasive BLCA accounts for over 75% of all BLCA cases. The imbalance of tumor metabolic pathways is associated with tumor formation and proliferation. Pyrimidine me...
Main Authors: | Zixuan Wu, Xiaohuan Li, Zhenchang Gu, Xinhua Xia, Jing Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1102518/full |
Similar Items
-
Unlocking potential biomarkers bridging coronary atherosclerosis and pyrimidine metabolism-associated genes through an integrated bioinformatics and machine learning approach
by: Fanli Bu, et al.
Published: (2024-03-01) -
Identification of clinical prognostic factors and analysis of ferroptosis-related gene signatures in the bladder cancer immune microenvironment
by: Jiafu Ma, et al.
Published: (2024-01-01) -
Development and validation of prognostic index based on purine metabolism genes in patients with bladder cancer
by: Zixuan Wu, et al.
Published: (2023-09-01) -
Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival
by: Hui Li, et al.
Published: (2023-06-01) -
A novel cuproptosis-related lncRNAs signature predicts prognostic and immune of bladder urothelial carcinoma
by: Zheng Zhou, et al.
Published: (2023-03-01)